Veracyte, Inc.Equity-NMS: VCYT
Equity-NMS: VCYT
$23.62
+0.06
(9:00 pm IST)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$23.62
Open
$23.62
Today’s high
$23.80
Today’s low
$23.16
52W low
$19.52
52W high
$30.52
1Y
-4.02%
5Y
3.17%
PE
-34.45
EPS (TTM)
-0.69
Shares O/S
73.04M
Market cap
1.73B
Insights
VCYT price is below its 200 day moving average
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Veracyte, Inc.

Veracyte, Inc. is a global diagnostics company. The Company is engaged in the development and commercialization of diagnostic products and biopharmaceutical services. It offers tests for thyroid cancer (Afirma), prostate cancer (Decipher Prostate), breast cancer (Prosigna), interstitial lung diseases (Envisia), and bladder cancer (Decipher Bladder).

Its Percepta Nasal Swab test is being run in its Clinical Laboratory Improvement Amendments (CLIA) lab in support of clinical studies and its tests for kidney cancer and lymphoma are in development, the latter as a companion diagnostic. It also offers an Immunogram, which provides an understanding of the tumor immune microenvironment by integrating data from a variety of genomic, transcriptomic, and proteomic platforms. Its tests in the United States are serviced through its own CLIA-certified laboratories in South San Francisco and San Diego, California and Austin, Texas. It also offers customized biomarker testing and analytical services. .


FAQs

Can I buy Veracyte, Inc. shares in India?
How to buy Veracyte, Inc. shares in India?
What is the share price of Veracyte, Inc.?
What is the Market Capitalization of Veracyte, Inc.?
What is the PE ratio of Veracyte, Inc.?
Is Veracyte, Inc. a good stock to buy?
In which sector / industry does Veracyte, Inc. operate?